These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 32397027)
1. [Fertility analyses of patients with hematologic diseases after allogeneic hematopoietic stem cell transplantation]. Song XC; Song NX; Liu XM; Yu Z; Zhang H; Li X; He Q; Zhou F Zhonghua Xue Ye Xue Za Zhi; 2019 Jul; 40(7):605-607. PubMed ID: 32397027 [No Abstract] [Full Text] [Related]
4. [25 years allogenic bone marrow transplantation in Basel: 1973-1998]. Passweg JR; Gratwohl A; Tichelli A; Hoffmann T; Nissen C; Kühne T; Favre G; Avoledo P; Cornu P; Herrmann R; Jeannet M; Osterwalder B; Sartorius J; Schifferli JA; Signer E; Stauffacher W; Speck B Schweiz Med Wochenschr; 1998 Oct; 128(42):1568-74. PubMed ID: 9824884 [No Abstract] [Full Text] [Related]
5. Working together: establishment of the first national hematopoietic stem cell transplantation (HSCT) center in Sri Lanka. Abeysinghe P; Morawaka L; Gunasekara S; Suresh S; Udara PHSP; Siriwardena PPR; Milliken S; Ma DDF; Moore J Blood Adv; 2018 Nov; 2(Suppl 1):46-49. PubMed ID: 30504200 [No Abstract] [Full Text] [Related]
7. Peripheral blood vs bone marrow as a source for allogeneic hematopoietic stem cell transplantation. Mahmoud H; Fahmy O; Kamel A; Kamel M; El-Haddad A; El-Kadi D Bone Marrow Transplant; 1999 Aug; 24(4):355-8. PubMed ID: 10467322 [TBL] [Abstract][Full Text] [Related]
8. Allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning as treatment for hematologic malignancies and inherited blood disorders. Baron F; Storb R Mol Ther; 2006 Jan; 13(1):26-41. PubMed ID: 16280257 [TBL] [Abstract][Full Text] [Related]
9. Haematopoietic stem cell transplantation in South Africa: Current limitations and future perspectives. Grobbelaar S; Mercier AE; Verburgh E; Brittain D; Pepper MS S Afr Med J; 2019 Sep; 109(8b):46-52. PubMed ID: 31662149 [TBL] [Abstract][Full Text] [Related]
10. Allogeneic peripheral blood stem cell transplantation for hematologic diseases. Körbling M Cancer Treat Res; 1999; 101():1-23. PubMed ID: 10800642 [No Abstract] [Full Text] [Related]
11. Prospects and challenges of induced pluripotent stem cells as a source of hematopoietic stem cells. van Bekkum DW; Mikkers HM Ann N Y Acad Sci; 2012 Aug; 1266():179-88. PubMed ID: 22901269 [TBL] [Abstract][Full Text] [Related]
12. The clonogenic potential of hematopoietic stem cells and mesenchymal stromal cells in various hematologic diseases: a pilot study. Kurt Yüksel M; Topçuoğlu P; Kurdal M; Ilhan O Cytotherapy; 2010; 12(1):38-44. PubMed ID: 19878078 [TBL] [Abstract][Full Text] [Related]
13. Iron overload in hematologic malignancies and outcome of allogeneic hematopoietic stem cell transplantation. Koreth J; Antin JH Haematologica; 2010 Mar; 95(3):364-6. PubMed ID: 20207843 [No Abstract] [Full Text] [Related]
14. The role of natalizumab in hematopoietic stem cell mobilization. Neumann F; Zohren F; Haas R Expert Opin Biol Ther; 2009 Aug; 9(8):1099-106. PubMed ID: 19566481 [TBL] [Abstract][Full Text] [Related]
15. CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells. Hale G; Jacobs P; Wood L; Fibbe WE; Barge R; Novitzky N; Toit C; Abrahams L; Thomas V; Bunjes D; Duncker C; Wiesneth M; Selleslag D; Hidajat M; Starobinski M; Bird P; Waldmann H Bone Marrow Transplant; 2000 Jul; 26(1):69-76. PubMed ID: 10918407 [TBL] [Abstract][Full Text] [Related]